Log In
BCIQ
Print this Print this
 

A/H7N9 Influenza Rapid Test

  Manage Alerts
Collapse Summary General Information
Company Arbor Vita Corp.
DescriptionImmunoassay in a lateral flow configuration for in vitro detection of influenza A subtype H7N9 in nasal swab specimens
Molecular Target
Mechanism of ActionNA
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationInfectious, Diagnostic
Indication DetailsPresumptive detection of influenza A subtype H7N9
Regulatory Designation U.S. - Emergency Use Authorization (EUA) (Presumptive detection of influenza A subtype H7N9)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today